文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤

T4期前列腺癌直肠受侵增加直肠周围及肠系膜淋巴结受累风险

Increased Frequency of Mesorectal and Perirectal LN Involvement in T4 Prostate Cancers.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2020-04-27

该回顾性研究纳入103例初治cT4期前列腺癌患者,中位随访8年,评估淋巴结受累部位与失败模式。结果显示直肠受侵者直肠周围及肠系膜淋巴结受累率为45%,显著高于无直肠受侵者的26%(P < .05);膀胱或盆壁受侵与上述淋巴结受累频率无显著相关(P > .05)。结论提示T4期前列腺癌伴直肠受侵时,局部治疗应考虑调整靶区以覆盖直肠周围及肠系膜淋巴结。

要点

  • T4期前列腺癌伴直肠受侵者直肠周围/肠系膜淋巴结受累率达45%。
  • 无直肠受侵者上述淋巴结受累率为26%,两者差异有统计学意义(P < .05)。
  • 膀胱或盆壁受侵与直肠周围/肠系膜淋巴结受累频率无显著相关(P > .05)。

核心结论

  • T4期前列腺癌伴直肠受侵时,直肠周围及肠系膜淋巴结受累风险显著升高,局部治疗应考虑靶区调整以覆盖这些区域。

研究设计与样本

  • 回顾性识别初治cT4期前列腺癌患者,要求经泌尿生殖病理学家确诊并完成基线分期,共103例符合标准,中位随访8年(范围0.5-14年)。
  • 淋巴结受累及位置由泌尿生殖放射科医生审阅诊断时影像确定,随访影像结合淋巴结大小、影像特征及系统治疗下的进展/退缩记录失败部位,手术患者记录病理受累淋巴结及解剖位置。

主要发现

  • 直肠受侵者直肠周围及肠系膜淋巴结受累率为45%,无直肠受侵者为26%,差异有统计学意义(P < .05)。
  • 膀胱或盆壁受侵与直肠周围/肠系膜淋巴结受累频率增加无显著相关(P > .05)。
  • 上述直肠周围及肠系膜淋巴结区域通常不被常规盆腔外照射覆盖,也非常规盆腔淋巴结清扫范围。

关键数值与推荐

  • 直肠受侵者直肠周围及肠系膜淋巴结受累率45%,无直肠受侵者26%(P < .05)。
  • 膀胱或盆壁受侵与上述淋巴结受累频率无显著相关(P > .05)。

临床怎么用

  • 对T4期前列腺癌伴直肠受侵患者提供局部治疗时,应考虑调整靶区以包含直肠周围及肠系膜淋巴结。
  • 常规盆腔外照射和常规盆腔淋巴结清扫通常不覆盖直肠周围及肠系膜淋巴结区域,需特别关注。

局限性

  • 本研究为回顾性设计,样本量103例,中位随访8年(范围0.5-14年)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Patients with prostate cancer presenting with advanced T stage, mainly T4, might have a unique pattern of nodal failure and disease involvement that is not typically covered when local therapy is offered. We attempted to identify common sites of nodal disease presentation and failure for patients presenting with cT4 prostate cancer. METHODS AND MATERIALS: All patients with treatment-naïve cT4 prostate cancer were retrospectively identified. All patients were required to have a confirmed diagnosis reviewed by our genitourinary pathologist and completed baseline staging. Lymph node (LN) involvement and location at diagnosis were reviewed by a genitourinary radiologist. All patients' follow-up scans were also reviewed; based on LN size, imaging characteristics, and progression/regression characteristics on systemic therapy, the locations of sites of LN failure were recorded. For patients who underwent surgery, any pathologically involved LNs and their anatomic locations were recorded. A total of 103 patients met these criteria, with a median follow-up of 8 years (range, 0.5-14 years). RESULTS: Rectal involvement by the primary disease was associated with a higher risk of perirectal and mesorectal LN involvement (45%) relative to no rectal involvement (26%) (P < .05). These echelons are typically not covered with conventional pelvic external beam radiation therapy and are not routinely part of pelvic LN dissection in patients treated surgically. Conversely, bladder or pelvic side wall invasion did not correlate with increased frequency of involvement of perirectal/mesorectal LNs (P > .05). CONCLUSIONS: When offering local therapy, target modification to include the perirectal and mesorectal LNs should be considered for patients presenting with T4 prostate cancer with rectal involvement.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Abu-Gheida I, Bathala TK, Maldonado JA, et al. Increased Frequency of Mesorectal and Perirectal LN Involvement in T4 Prostate Cancers. Int J Radiat Oncol Biol Phys. 2020. PMID: 32353391. doi:10.1016/j.ijrobp.2020.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。